| First Author | Shinoda K | Year | 2021 |
| Journal | Mol Cell | Volume | 81 |
| Issue | 12 | Pages | 2611-2624.e10 |
| PubMed ID | 33857404 | Mgi Jnum | J:307190 |
| Mgi Id | MGI:6718905 | Doi | 10.1016/j.molcel.2021.03.034 |
| Citation | Shinoda K, et al. (2021) The dystonia gene THAP1 controls DNA double-strand break repair choice. Mol Cell 81(12):2611-2624.e10 |
| abstractText | The Shieldin complex shields double-strand DNA breaks (DSBs) from nucleolytic resection. Curiously, the penultimate Shieldin component, SHLD1, is one of the least abundant mammalian proteins. Here, we report that the transcription factors THAP1, YY1, and HCF1 bind directly to the SHLD1 promoter, where they cooperatively maintain the low basal expression of SHLD1, thereby ensuring a proper balance between end protection and resection during DSB repair. The loss of THAP1-dependent SHLD1 expression confers cross-resistance to poly (ADP-ribose) polymerase (PARP) inhibitor and cisplatin in BRCA1-deficient cells and shorter progression-free survival in ovarian cancer patients. Moreover, the embryonic lethality and PARPi sensitivity of BRCA1-deficient mice is rescued by ablation of SHLD1. Our study uncovers a transcriptional network that directly controls DSB repair choice and suggests a potential link between DNA damage and pathogenic THAP1 mutations, found in patients with the neurodevelopmental movement disorder adult-onset torsion dystonia type 6. |
